Immunotherapy drug pembrolizumab (Keytruda) now available on the NHS in England
This new immunotherapy drug was initially rejected in January 2020 but has now been approved by NICE - who estimate that around 950 people will be eligible for the treatment.
Get in touch
Oracle Cancer Trust is a registered charity in England and Wales (1142037). A company limited by guarantee. Registered company in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS